Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb;21(2):426-430.
doi: 10.1038/s41436-018-0063-z. Epub 2018 Jun 6.

The impact of variant classification on the clinical management of hereditary cancer syndromes

Scott A Turner  1 , Smita K Rao  2 , R Hayes Morgan  2 , Cindy L Vnencak-Jones  3 , Georgia L Wiesner  2   4
Affiliations
Free article
Case Reports

The impact of variant classification on the clinical management of hereditary cancer syndromes

Scott A Turner et al. Genet Med. 2019 Feb.
Free article

Abstract

Purpose: The reclassification of genetic variants poses a significant challenge for laboratories and clinicians. Variant review has resulted in the reclassification of variants of unknown significance as well as the reclassification of previously established pathogenic and likely pathogenic variants. These reclassifications have the potential to alter the clinical management of patients with hereditary cancer syndromes.

Methods: Results were reviewed for 1694 patients seen for hereditary cancer evaluation between August 2012 and May 2017 to determine the frequency and types of variant reclassification. Patients with reclassifications with high potential for impact were monitored for alterations in organ surveillance, prophylactic surgery, and cascade testing.

Results: One hundred forty-two variants were reclassified representing 124/1694 (7.3%) patients; 11.3% of reclassifications (16/142) had a high potential for clinical impact with 94% (15/16) altering clinical management of patients with 56% (9/16) changing multiple areas of management.

Conclusion: While reclassifications are rare, the impact on clinical management is profound. In many cases, patients with downgraded pathogenic/likely pathogenic variants had years of unnecessary organ surveillance and underwent unneeded surgical intervention. In addition, cascade testing misidentified those at risk for developing cancers, thereby altering the management across generations. The frequency and types of alterations to clinical management highlight the need for timely variant reclassification.

Keywords: Clinical impact; Hereditary cancer clinic; Hereditary cancer syndrome; Variant reclassification,.

PubMed Disclaimer

References

    1. Ricker C, Culver JO, Lowstuter K et al. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genet. 2016;209:130–7. - DOI
    1. Hermel DJ, McKinnon WC, Wood ME et al. Multi-gene panel testing for hereditary cancer susceptibility in a rural familial cancer program. Fam Cancer. 2017;16:159–66. - DOI
    1. Mauer CB, Pirzadeh-Miller SM, Robinson LD et al. The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience. Genet Med. 2014;16:407–12. - DOI
    1. Yorczyk A, Robinson LS, Ross TS. Use of panel tests in place of single gene tests in the cancer genetics clinic. Clin Genet. 2015;88:278–82. - DOI
    1. Nagy R, Sweet K, Eng C. Highly penetrant hereditary cancer syndromes. Oncogene. 2004;23:6445–70. - DOI

Publication types

LinkOut - more resources